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as an option for detection of endoleaks in
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repair procedure
Eijun Sueyoshi, MD, Hiroki Nagayama, MD, Ichiro Sakamoto, MD, and Masataka Uetani, MD, Nagasaki,
Japan
Objective: The purpose of this study was to evaluate carbon dioxide digital subtraction angiography (CO2-DSA) as
an option for the detection of endoleaks (ELs) in the endovascular abdominal aortic aneurysm repair (EVAR)
procedure.
Methods: Forty patients with abdominal aortic aneurysm who were scheduled to undergo EVAR were enrolled in
the study. There were 35 men and ﬁve women (mean age, 77.9 years). All patients had both iodinated contrast
conventional DSA (C-DSA) and CO2-DSA immediately after EVAR. The sensitivity and speciﬁcity were calculated
for the ability of CO2-DSA to detect ELs. We also correlated with computed tomography ﬁndings 6 months after
EVAR.
Results: C-DSA showed that 27 of the 40 patients (68%) had 28 ELs (type I, four; type II, 20; type III, three; type IV,
one). CO2-DSA showed that 16 of the 40 patients (40%) had 17 ELs (type I, four; type II, 10; type III, three; type
IV, none). For the prediction of direct ELs (type I and type III) with use of C-DSA as the criterion standard, CO2-DSA
has a sensitivity of 1.0 and a speciﬁcity of 1.0. For the detection of persistent type II ELs (n[ 11) with use of computed
tomography ﬁndings 6 months from EVAR as the criterion standard, CO2-DSA has a sensitivity of 0.87 and a speciﬁcity
of 0.97. C-DSA has a sensitivity of 0.82 and a speciﬁcity of 0.64.
Conclusions: CO2-DSA is reliable for the detection of direct ELs and persistent type II ELs in EVAR. CO2-DSA can be an
option to detect ELs in the EVAR procedure. (J Vasc Surg 2015;61:298-303.)Endovascular aortic aneurysm repair (EVAR) has
become one of the treatment modalities for abdominal
aortic aneurysm (AAA) with suitable anatomy. The beneﬁts
of EVAR include lower short-term morbidity and mortality
than with open surgery.1-3 However, the use of iodinated
contrast conventional digital subtraction angiography
(C-DSA) during EVAR can lead to potential adverse events
for patients with known allergy to contrast material or who
are at risk for contrast-induced nephropathy.4,5 Carbon
dioxide is a non-nephrotoxic, nonallergenic gas and is a
potential substitute for C-DSA in EVAR. The use of car-
bon dioxide digital subtraction angiography (CO2-DSA)
has been studied extensively since the development of a
safe and efﬁcient delivery system.6,7 However, a recent
study showed that CO2-DSA is not a reliable method to
detect type II endoleaks (ELs) intraoperatively with use
of C-DSA as the criterion standard.7 The purpose ofthe Department of Radiology, Nagasaki University School of
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detection of ELs in the EVAR procedure.
METHODS
The research protocol was approved and reviewed by
the Institutional Review Board. Informed consent of the
patients was obtained.
We performed this prospective study between 2011
and 2013 at our hospital. Forty patients with infrarenal
AAA who were scheduled to undergo EVAR were enrolled
in the study. They consisted of 35 men and ﬁve women be-
tween the ages of 75 and 83 years (mean age, 77.9 6
8.4 years) (Table I). No patient had renal dysfunction
because we eliminated patients with renal dysfunction
from this study. All patients underwent both C-DSA and
CO2-DSA immediately after EVAR for infrarenal AAA.
Also, all patients were followed up by computed tomogra-
phy (CT) for more than 6 months after EVAR (mean,
12.5 6 2.5 months).
All patients underwent infrarenal EVAR with iodinated
contrast material (iomeprol, Iomeron 300; Bracco, Milan,
Italy). Two commercially available endografts were used:
Excluder (W. L. Gore & Associates, Flagstaff, Ariz; n ¼
24) and Zenith (Cook, Bloomington, Ind; n ¼ 16).
The type of endograft used was determined by the physi-
cian’s preference based on the patient’s anatomy. All proce-
dures were performed under general anesthesia in a hybrid
endovascular operating room with ﬁxed angiographic
Table I. Baseline characteristics of 40 patients
Characteristics Patients (N ¼ 40)
Age, years 77.9 6 8.4
Female gender 5 (13)
Hypertension 36 (90)
Coronary artery disease 6 (15)
Current smoking 20 (50)
Hyperlipidemia 12 (30)
Diabetes mellitus 9 (23)
Continuous data are presented as mean 6 standard deviation and cate-
gorical data as number (%).
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Germany) with a CO2 imaging package.
Our technique for CO2-DSA was as follows. A sterile
bag (Merit Medical, South Jordan, Utah) with attached
tubing with a three-way stopcock (Terumo, Tokyo, Japan)
was ﬁlled with CO2. The bag was purged and ﬁlled with
CO2 three times to remove room air contamination. The
stopcock was then closed, cutting off connection to the
inﬂated bag, while connecting to the tubing with a one-
way valve to a sidearm (Terumo). The sidearm of the
tubing was connected to a 30-mL lock syringe (Terumo).
The lock syringe was ﬁlled and purged at least three
times before hand injection. These steps create a closed
CO2 system. Hand injection of 30 mL/s with DSA was
performed. High frame rates of six frames per second and
stacking technology were required to produce adequate
images. After undergoing a standard procedure with iodin-
ated contrast material for the proper deployment of an
endograft, each patient underwent one anteroposterior
view C-DSA and CO2-DSA.
After EVAR, paired C-DSA and CO2-DSA were per-
formed immediately. If type I or type III ELs were identi-
ﬁed, additional treatment for EL was performed. If
additional treatment was performed, only C-DSA was per-
formed after treatment to avoid prolonged procedure time.
However, these data were not evaluated. In this study,
paired C-DSA and CO2-DSA studies were evaluated
immediately after EVAR.
After completion of EVAR for all patients, the inter-
preting radiologists were blinded to the patient’s identity
by replacement of any identiﬁers on the workstation of
the angiograms. All cases with no patient identiﬁers were
reviewed at once by two experienced cardiovascular radiol-
ogists (each radiologist with more than 10 years of experi-
ence). Final decisions about the DSA ﬁndings were reached
by consensus.
After EVAR, follow-up CT studies were done at
1 week, 1 month, and 6 months in all patients. CT was ob-
tained by Somatom Deﬁnition (Siemens Medical Solu-
tions) before and after EVAR. Axial CT images were
evaluated in a contiguous 1-mm-thick section. Unen-
hanced and contrast-enhanced CT images were obtained
from the thoracic inlet to the inguinal level. Coronal and
sagittal reformatted images were also evaluated. A total of
100 mL of contrast material (iomeprol, Iomeron 300;Bracco) was injected intravenously at a rate of 3 mL/s, fol-
lowed by a saline chaser with an automated injector. Our
standard triple-phase CT protocol was performed in all
cases. This protocol consists of unenhanced acquisition,
an arterial phase, and a late delayed phase; all were acquired
during an inspiratory breath-hold.
CT studies were retrospectively evaluated by two expe-
rienced cardiovascular radiologists (each with more than
5 years of experience) who were blinded to the patient’s
clinical information and previous imaging ﬁndings. Axial
images as well as multiplanar reconstructions were reviewed
on external workstations. Final decisions about the CT
ﬁndings were reached by consensus.
For each case, the presence of an ELwas assessed. An EL
was deﬁned as the presence of contrast material within the
aneurysm sac beyond the graft on the arterial or delayed
phase image and the absence of contrast material in the cor-
responding location on the unenhanced image, virtual or
standard. ELs were classiﬁed as previously described8: type
I, leak caused by incomplete attachment of the proximal or
distal portion of the prosthesis due to technical or anatomic
problems; type II, leak caused by retrograde ﬂow into the
aneurysm sac through aortic collateral arteries; type III,
leak caused by graft defect or a graft module disconnection;
and type IV, leak caused by the porosity of the prosthesis.
In this study, direct ELs were deﬁned as type I and type
III ELs, which have high-risk leaks and high pressure and
require urgent management.9 Persistent EL was deﬁned
as an EL that did not disappear >6 months because previ-
ous studies revealed that patients with persistent type II
ELs (>6 months) should be considered for more frequent
follow-up or a more aggressive approach to reinterven-
tion.10 On CT 6 months after EVAR, any remaining ELs
were deﬁned as persistent ELs.10
Statistical analysis. All values are shown as the
mean 6 standard deviation. Statistical analysis was done
with clinical and morphologic variables by the paired
t-test or the Mann-Whitney U test for continuous vari-
ables. In all tests, P < .05 was considered signiﬁcant
(release 11.5; SPSS, Chicago, Ill).
The interpretations were compared between radiolo-
gist 1 and radiologist 2. The Cohen k statistic was per-
formed to assess interobserver agreement. The Cohen k
coefﬁcient is accepted as a stringent statistical method for
comparing two observers.11 The k coefﬁcients were calcu-
lated for the detection of ELs.
After a consensus was obtained for C-DSA and CO2-
DSA as described before, the ﬁnal diagnoses were used to
calculate statistical measures. The ﬁnal C-DSA diagnosis
was used as the criterion standard. The true positives,
true negatives, false positives, and false negatives of CO2-
DSA were calculated for detection of ELs in the EVAR
procedure. The sensitivity, speciﬁcity, positive predictive
value (PPV), and negative predictive value (NPV) of
CO2-DSA were calculated. The diagnostic accuracy was
compared by the Fisher test.
After a consensus was obtained for CT ﬁndings of
persistent ELs 6 months after EVAR as described before,
Table II. Sensitivity, speciﬁcity, positive predictive value
(PPV), and negative predictive value (NPV) of CO2-DSA
for the detection of endoleak (EL) immediately after
EVAR
EL type Sensitivity Speciﬁcity PPV NPV
All types 0.61 1 1 0.54
Type I 1 1 1 1
Type II 0.5 1 1 0.67
Type III 1 1 1 1
Types I and III 1 1 1 1
CO2-DSA, Carbon dioxide digital subtraction angiography; EVAR, endo-
vascular aneurysm repair.
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sures. The CT ﬁndings of persistent ELs were used as the
criterion standard. The true positives, true negatives, false
positives, and false negatives of C-DSA and CO2-DSA
were calculated for detection of persistent ELs. The sensi-
tivity, speciﬁcity, PPV, and NPV of C-DSA and CO2-DSA
were calculated.RESULTS
C-DSA vs CO2-DSA immediately after EVAR. In
all EVAR procedures, the mean iodinated contrast material
used was 128 6 32 mL. The mean ﬂuoroscopy time was
42 6 23 minutes.
C-DSA showed that 27 of the 40 patients (68%) had
28 ELs (type I, four; type II, 20; type III, three; type IV,
one). One patient had two types of ELs (type I and type
II). On the other hand, CO2-DSA showed that 16 of the
40 patients (40%) had 17 ELs (type I, 4; type II, 10;
type III, 3; type IV, 0). One patient had two types of
ELs (type I and type II). Type II ELs seen on C-DSA
but not on CO2-DSA were supplied by the lumbar artery
(n ¼ 5) and inferior mesenteric artery (n ¼ 5) on
C-DSA. There was not a signiﬁcant difference in size of
AAA between type II EL groups identiﬁed (mean diam-
eter, 5.8 6 1.5 cm) and not identiﬁed (mean diameter,
5.9 6 1.6 cm) by CO2-DSA.
The interobserver agreement between radiologist 1
and radiologist 2 for the detection of ELs, with use of C-
DSA, was 0.68. The same k statistic for interpretation
with use of CO2 was 0.65.
Seven direct ELs (type I, four; type III, three) were
identiﬁed immediately after deployment. Additional treat-
ments for high-ﬂow-type ELs (subsequent balloon angio-
plasty, six; aortic cuff placement, one) were performed.
Finally, all direct ELs disappeared on C-DSA.
For the detection of any ELs with use of C-DSA as the
criterion standard, CO2-DSA has a sensitivity of 0.61 and a
speciﬁcity of 1.00 (Table II; Figs 1-3). The PPV was 1.00,
and the NPV was 0.54. The results were compared among
patients grouped by body mass index (BMI) and between
patients with a BMI <25 and those with a BMI $25.
Seventeen patients had a BMI <25, and 23 patients had
a BMI $25. No statistically signiﬁcant difference wasseen between the accuracy rates for the diagnosis of ELs
(70.6% vs 73.5%, respectively).
For the detection of type I ELs with use of C-DSA as
the criterion standard, CO2-DSA has a sensitivity of 1.00
and a speciﬁcity of 1.00 (Table II). The PPV was 1.00,
and the NPV was 1.00.
For the detection of type II ELs only with use of C-
DSA as the criterion standard, CO2-DSA has a sensitivity
of 0.50 and a speciﬁcity of 1.00 (Table II). The PPV was
1.00, and the NPV was 0.67.
For the detection of type III ELs only with use of C-
DSA as the criterion standard, CO2-DSA has a sensitivity
of 1.00 and a speciﬁcity of 1.00 (Table II). The PPV was
1.00, and the NPV was 1.00.
For the detection of direct ELs including type I and
type III ELs with use of C-DSA as the criterion standard,
CO2-DSA has a sensitivity of 1.00 and a speciﬁcity of
1.00 (Table II). The PPV was 1.00, and the NPV was 1.00.
Preprocedure and postprocedure serum creatine data
were available in all patients. The mean preprocedure and
postprocedure values were 0.95 6 0.34 and 0.96 6
0.41 mg/dL, respectively. There was no signiﬁcant differ-
ence between them. Otherwise, no patients had any com-
plications due to CO2-DSA.
C-DSA vs CO2-DSA 6 months after EVAR. All type
I, type III, and type IV ELs in eight patients had disap-
peared 1 week after EVAR on CT. Six months after
EVAR, CT studies did not show any type I, type III, and
type IV ELs.
Nine of 20 type II ELs identiﬁed by C-DSA (45%)
were persistent 6 months after EVAR. The remaining 11
of 20 type II ELs identiﬁed by C-DSA (55%) had disap-
peared 1 week after EVAR on CT. On the other hand,
nine of 10 persistent type II ELs identiﬁed by CO2-DSA
(90%) were persistent. One remaining type II EL identiﬁed
by CO2-DSA had disappeared 1 week after EVAR on CT.
Of the 10 type II ELs seen on C-DSA but not on CO2-
DSA, none progressed to persistent type II ELs.
During the follow-up period, four new type II ELs
appeared at 1 week (n ¼ 3) and 3 months (n ¼ 1) after
EVAR. Two of the four newly identiﬁed type II ELs had dis-
appeared 6 months after EVAR, but two of the newly iden-
tiﬁed type II ELs remained, which were persistent type II
ELs. Six months after EVAR, CT studies showed 11 persis-
tent type II ELs. Ten of 11 patients with a persistent type
II EL had no increase in size of the AAA. One remaining
patient had an increase in size of the AAA (1 mm).
For the detection of persistent type II ELs (n ¼ 11)
with use of CT ﬁndings 6 months after EVAR as the crite-
rion standard, CO2-DSA had a sensitivity of 0.87 and a
speciﬁcity of 0.97. The PPV was 0.90, and the NPV was
0.93. On the other hand, C-DSA had a sensitivity of
0.82 and a speciﬁcity of 0.64. The PPV was 0.45, and
the NPV was 0.90.
DISCUSSION
The use of CO2 arteriography was ﬁrst developed by
Hawkins in 1982.12 Since then, it has been recognized
Fig 1. An 81-year-old man after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A,
Conventional digital subtraction angiography (C-DSA) image shows type II endoleak (EL) through lumbar arteries
(arrow). B, Carbon dioxide digital subtraction angiography (CO2-DSA) image also shows type II EL through lumbar
arteries (arrows).
Fig 2. An 83-year-old man after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A and
B, Conventional digital subtraction angiography (C-DSA) images show type II endoleak (EL) through lumbar arteries
(arrow). C, On carbon dioxide digital subtraction angiography (CO2-DSA) image, type II EL cannot be identiﬁed.
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contrast agent for angiography.12,13 Two of the most
appealing characteristics of CO2 are that it is non-
nephrotoxic and nonallergenic.
In this study, no patients had any complications due to
CO2-DSA. According to previous reports, vapor lock canoccur by trapped CO2 gas in the vessels. In fact, the vol-
umes of CO2 injected are too low to cause this complica-
tion.7,13 Vapor lock of the mesenteric arteries can cause
transient intestinal ischemia, but this complication can
easily be prevented by aspirating trapped CO2 through
the angiographic catheter.13 Some authors believe that
Fig 3. An 80-year-old man after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A,
Conventional digital subtraction angiography (C-DSA) image shows type III endoleak (EL) (arrow). B and C, Carbon
dioxide digital subtraction angiography (CO2-DSA) images also show type III EL (arrow).
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contamination because the dissolution of CO2 begins
almost instantaneously after displacement, allowing rapid
pulmonary elimination.7
Taking advantage of these properties of CO2 requires
an advanced ﬂuoroscopic imaging modality equipped
with adequate mobility and digital subtraction to maximize
the beneﬁt of its nondependent preference and to capture
its rapid disappearance with a higher frame rate.
So far, multiple studies have shown the safety and feasi-
bility of CO2 angiography in EVAR.
7,14-18 Also, a few
studies have shown the accuracy of CO2-DSA in detecting
ELs.16,17,19 Huang et al reported that the sensitivity to
detect any EL and both the sensitivity and speciﬁcity to
detect type I ELs with CO2-DSA are acceptable.
7 How-
ever, for detection of type II ELs with CO2-DSA, the sensi-
tivity and PPV are poor.7 In this study, both the sensitivity
and speciﬁcity to detect type I and type III ELs with CO2-
DSA were good. However, for detection of type II ELs
with CO2-DSA, the sensitivity and PPV were poor, which
were ﬁndings similar to those of previous reports.7 Accord-
ing to previous reports, this may be related to the fact that
CO2 is a gas, and to achieve a useful angiogram, the relative
position of the area being imaged must be nondepen-
dent.13 Type II ELs are attributed to back-bleeding from
aortic branches. The lumbar branches are posterior in loca-
tion. With the patient supine, CO2 is unlikely to distribute
posteriorly, thereby not revealing type II ELs on the angio-
gram. However, our results showed that type II ELs seen
on C-DSA but not on CO2-DSA were supplied by the lum-
bar artery (n ¼ 5) and inferior mesenteric artery (n ¼ 5) on
C-DSA. We speculate that the volume and speed of blood
ﬂow may contribute to visualization of CO2-DSA more
than the location of the artery.13 This would also explain
why CO2-DSA-positive type II ELs tend to persist. In
this study, for the detection of persistent type II ELs
with use of CT ﬁndings 6 months after EVAR as the crite-
rion standard, CO2-DSA had high sensitivity and speci-
ﬁcity. In this study, for the detection of direct ELs
including type I and type III ELs with use of C-DSA asthe criterion standard, CO2-DSA had high sensitivity and
speciﬁcity. In addition, the interobserver agreement for
the detection of any ELs by CO2-DSA was high. These re-
sults suggest that CO2-DSA is reliable to detect direct ELs,
including type I and type II ELs.9 In fact, type IV ELs are
not clinical problems, and many type II ELs disappear dur-
ing the follow-up period. Only persistent type II ELs can
be a clinical problem. According to previous reports, persis-
tent type II ELs increase the incidence of poor outcomes,
including aneurysm sac growth, reintervention rate, need
for conversion to open repair, and rupture. In patients
with persistent type II ELs (>6 months), more frequent
follow-up or reintervention should be considered.10 This
study revealed that CO2-DSA is more reliable than C-
DSA for the prediction of persistent type II ELs in
EVAR. In addition, CO2-DSA had high sensitivity and
speciﬁcity to detect direct ELs. Therefore, CO2-DSA can
be an option to detect ELs during the EVAR procedure.
CO2-DSA during EVAR can reduce the dose of contrast
material and the risk for contrast-induced nephropathy in
patients with renal dysfunction.
A previous study revealed that the interobserver agree-
ment between observers 1 and 2 for the detection of ELs
with use of C-DSA was similar.7 However, the same k sta-
tistics for interpretation with use of CO2-DSA varied
widely.7 In this study, the interobserver agreement between
radiologist 1 and radiologist 2 for the detection of ELs, with
use of both C-DSA and CO2-DSA, was similar. The reason
that the difference occurred is unknown. However, there
were several differences in the methods between our study
and previous studies, and further studies are needed to
clarify the interobserver agreement with use of CO2-DSA.
A few reports have shown that only CO2-DSA was
used during the whole EVAR procedure.13-15,20 However,
in some cases, C-DSA was needed because of the low qual-
ity of CO2 vascular images.
12,20 If the operator is well
informed about using CO2, many EVAR procedures could
be performed with CO2-DSA alone.
In this study, the incidence of ELs (68%) on C-DSA
was higher than in previous reports because DSAs were
JOURNAL OF VASCULAR SURGERY
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ELs were identiﬁed, additional treatment for EL was per-
formed. If additional treatment was performed, we
conﬁrmed disappearance of type I or type III ELs by
C-DSA. Therefore, all type I and type III ELs ﬁnally disap-
peared during the EVAR procedure. Many type II ELs dis-
appeared during the follow-up period. Six months after
EVAR, the incidence of ELs (28%) on CT was not higher
than in previous reports.7 During the follow-up period,
four new type II ELs appeared from 1 week to 3 months
after EVAR. It is difﬁcult to predict new ELs, and
follow-up imaging studies are needed.
There were the following limitations in this study. First,
the number of patients was small; additional studies
involving larger numbers of patients are required. Second,
we used two types of stent graft, which may have a poten-
tial bias; however, there were no episodes based on the type
of stent graft in this study. Third, it is not clear whether our
injection method of CO2 is the best way to depict ELs. It is
therefore necessary to perform optimization studies.
CONCLUSIONS
This study limited to 40 patients revealed that CO2-
DSA exhibited only a moderate sensitivity and speciﬁcity.
However, CO2-DSA was able to predict persistent type
II ELs with a high sensitivity and speciﬁcity. Type II ELs
missed on CO2-DSA were not a problem in the short
term. Therefore, CO2-DSA can be an option to detect
ELs during the EVAR procedure, and it may reduce the
dose of contrast material and the risk for contrast-
induced nephropathy in patients with renal dysfunction.
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